Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | ORICOric Pharmaceuticals, Inc.FY2025 · Dec |
|---|---|
| Revenue | — |
| Revenue, yoy | — |
| Net income | $129.47M |
| Net income, yoy | −1.3% |
| Net margin | — |
| Free cash flow | $111.68M |
| FCF margin | — |
| EPS, diluted | $1.47 |
Add another company.
No annual figures on file for this.